In a laboratory in Greifswald, Germany, scientists have discovered that the humble larvae of the greater wax moth may soon spare thousands of mammals from infection research. Researchers at the Helmholtz Institute for One Health have validated these insects as a reliable, ethically acceptable model for testing bacterial virulence—a finding that could reshape how scientists screen dangerous pathogens without resorting to mice and other mammals.
Understanding how dangerous a bacterium truly is in a living body has long required testing on animals. While genetic sequencing can now reveal a pathogen's disease-causing potential in minutes, determining its actual virulence in a living organism remains far more complex and resource-intensive. Mammalian models have been the gold standard, but they're slow, expensive, and raise ethical concerns—particularly for high-throughput screening where researchers need to test dozens or hundreds of variants quickly. This mismatch between speed of genetic analysis and sluggish virulence testing has created a bottleneck in infection research.
Katharina Schaufler and her interdisciplinary team at HIOH tackled this problem by systematically optimizing the wax moth larva as an infection model. They tested 80 different strains of Klebsiella pneumoniae, one of the world's most dangerous pathogens and a major cause of severe infections in hospitals and clinical settings. Under carefully standardized conditions, the researchers found they could reliably distinguish between classic bacterial variants and particularly virulent ones—a critical ability for identifying which pathogens warrant further study.
The breakthrough lies not just in proving the model works, but in establishing the precise conditions that make it work consistently. Previous research using wax moth larvae had been viewed skeptically because results were difficult to compare across studies. Schaufler's team addressed this by developing standardized protocols aligned with the 3R principle—an ethical framework for Replacement, Reduction, and Refinement of animal testing. "As a veterinarian, animal welfare is particularly important to me," Schaufler explains. "However, to better understand the characteristics of antibiotic-resistant pathogens, we need reliable in vivo models. Our work details the conditions under which the insect model yields reproducible results."
What makes the wax moth larva particularly powerful is its scalability. Researchers can screen large numbers of bacterial strains or test new drug candidates in a living system before investing time and resources in mammalian experiments. As Elias Eger, the study's corresponding author, notes, the model works "excellently as a tool for informed preselection. This means that only the most promising bacterial isolates need to be validated in more complex mammalian models afterward."
The findings, published in The Lancet Microbe, address a genuine gap in infection research. HIOH's broader mission involves understanding how antibiotic-resistant pathogens spread and evolve across environmental, animal, and human populations—dynamics that require practical, scalable in vivo testing. The standardized wax moth model fills that need.
This is not a complete replacement for mammalian research, but rather a smarter, more humane way to narrow the field before conducting more complex and costly studies. For labs worldwide working to combat antimicrobial resistance, the wax moth larva represents both a scientific advance and an ethical one.